These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31278009)

  • 1. Mutations in TP53, ZNF750, and RB1 typify ocular sebaceous carcinoma.
    Bao Y; Selfridge JE; Wang J; Zhao Y; Cui J; Guda K; Wang Z; Zhu Y
    J Genet Genomics; 2019 Jun; 46(6):315-318. PubMed ID: 31278009
    [No Abstract]   [Full Text] [Related]  

  • 2. NGS Analysis Confirms Common
    Peterson C; Moore R; Hicks JL; Morsberger LA; De Marzo AM; Zou Y; Eberhart CG; Campbell AA
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-exome sequencing for ocular adnexal sebaceous carcinoma suggests PCDH15 as a novel mutation associated with metastasis.
    Xu S; Moss TJ; Laura Rubin M; Ning J; Eterovic K; Yu H; Jia R; Fan X; Tetzlaff MT; Esmaeli B
    Mod Pathol; 2020 Jul; 33(7):1256-1263. PubMed ID: 31937901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma.
    Tetzlaff MT; Singh RR; Seviour EG; Curry JL; Hudgens CW; Bell D; Wimmer DA; Ning J; Czerniak BA; Zhang L; Davies MA; Prieto VG; Broaddus RR; Ram P; Luthra R; Esmaeli B
    J Pathol; 2016 Sep; 240(1):84-95. PubMed ID: 27287813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic Alterations.
    Tetzlaff MT; Curry JL; Ning J; Sagiv O; Kandl TL; Peng B; Bell D; Routbort M; Hudgens CW; Ivan D; Kim TB; Chen K; Eterovic AK; Shaw K; Prieto VG; Yemelyanova A; Esmaeli B
    Clin Cancer Res; 2019 Feb; 25(4):1280-1290. PubMed ID: 30420449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivating Mutations of RB1 and TP53 Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal Tumors.
    Merten L; Agaimy A; Moskalev EA; Giedl J; Kayser C; Geddert H; Schaefer IM; Cameron S; Werner M; Ströbel P; Hartmann A; Haller F
    Am J Clin Pathol; 2016 Dec; 146(6):718-726. PubMed ID: 28028119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
    Manzano RG; Catalan-Latorre A; Brugarolas A
    BMC Cancer; 2021 Apr; 21(1):432. PubMed ID: 33879103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of RB1 gene mutation type in retinoblastoma patients on clinical presentation and management outcome.
    Mehyar M; Mosallam M; Tbakhi A; Saab A; Sultan I; Deebajah R; Jaradat I; AlJabari R; Mohammad M; AlNawaiseh I; Al-Hussaini M; Yousef YA
    Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):152-159. PubMed ID: 32222358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Alterations of Both MEN1/ATRX and TP53/RB1 in Pancreatic Neuroendocrine Neoplasms.
    Zhang MY; He D; Zhang S; Liu JY
    Pancreas; 2022 Jul; 51(6):e91-e93. PubMed ID: 36206476
    [No Abstract]   [Full Text] [Related]  

  • 10. Dysplastic Lipoma: A Distinctive Atypical Lipomatous Neoplasm With Anisocytosis, Focal Nuclear Atypia, p53 Overexpression, and a Lack of MDM2 Gene Amplification by FISH; A Report of 66 Cases Demonstrating Occasional Multifocality and a Rare Association With Retinoblastoma.
    Michal M; Agaimy A; Contreras AL; Svajdler M; Kazakov DV; Steiner P; Grossmann P; Martinek P; Hadravsky L; Michalova K; Svajdler P; Szep Z; Michal M; Fetsch JF
    Am J Surg Pathol; 2018 Nov; 42(11):1530-1540. PubMed ID: 30001242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle-invasive Urothelial Cancer: Association of Mutational Status with Metastatic Pattern and Survival.
    Alessandrino F; Williams K; Nassar AH; Gujrathi R; Silverman SG; Sonpavde G; Shinagare AB
    Radiology; 2020 Jun; 295(3):572-580. PubMed ID: 32228295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular diagnosis in patients with retinoblastoma: Report of a series of cases.
    Ossandón D; Zanolli M; López JP; Benavides F; Pérez V; Repetto GM
    Arch Soc Esp Oftalmol; 2016 Aug; 91(8):379-84. PubMed ID: 27021801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines.
    Schwermer M; Hiber M; Dreesmann S; Rieb A; Theißen J; Herold T; Schramm A; Temming P; Steenpass L
    Exp Cell Res; 2019 Feb; 375(2):92-99. PubMed ID: 30584916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress.
    Nyquist MD; Corella A; Coleman I; De Sarkar N; Kaipainen A; Ha G; Gulati R; Ang L; Chatterjee P; Lucas J; Pritchard C; Risbridger G; Isaacs J; Montgomery B; Morrissey C; Corey E; Nelson PS
    Cell Rep; 2020 May; 31(8):107669. PubMed ID: 32460015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-generation sequencing reveals mutations in RB1, CDK4 and TP53 that may promote chemo-resistance to palbociclib in ovarian cancer.
    El Shamieh S; Saleh F; Assaad S; Farhat F
    Drug Metab Pers Ther; 2019 May; 34(2):. PubMed ID: 31145688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-exome sequencing in osteosarcoma reveals important heterogeneity of genetic alterations.
    Bousquet M; Noirot C; Accadbled F; Sales de Gauzy J; Castex MP; Brousset P; Gomez-Brouchet A
    Ann Oncol; 2016 Apr; 27(4):738-44. PubMed ID: 26787232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder.
    Liu F; Li Y; Ying D; Qiu S; He Y; Li M; Liu Y; Zhang Y; Zhu Q; Hu Y; Liu L; Li G; Pan W; Jin W; Mu J; Cao Y; Liu Y
    Signal Transduct Target Ther; 2021 Feb; 6(1):55. PubMed ID: 33563892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anisometric Cell and Dysplastic Lipomas in a Retinoblastoma Patient.
    den Bakker MA; den Toom DT; Damen THC; Sleddens HFBM; Meijssen IC; Deloose S; Kliffen M; Dinjens WNM
    Int J Surg Pathol; 2020 Oct; 28(7):793-798. PubMed ID: 32362169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer.
    Mu P; Zhang Z; Benelli M; Karthaus WR; Hoover E; Chen CC; Wongvipat J; Ku SY; Gao D; Cao Z; Shah N; Adams EJ; Abida W; Watson PA; Prandi D; Huang CH; de Stanchina E; Lowe SW; Ellis L; Beltran H; Rubin MA; Goodrich DW; Demichelis F; Sawyers CL
    Science; 2017 Jan; 355(6320):84-88. PubMed ID: 28059768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.